+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diabetic Eye Disease Devices Market - Global Forecast 2026-2032- Product Image
Diabetic Eye Disease Devices Market - Global Forecast 2026-2032- Product Image
Sale

Diabetic Eye Disease Devices Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015430
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Diabetic Eye Disease Devices Market is projected to reach USD 22.89 Billion in 2026. It is expected to continue growing at a CAGR of 10.33%, reaching USD 41.42 Billion by 2032.

Diabetic Eye Disease Devices: Executive Overview

Diabetic eye disease devices support screening, diagnosis, monitoring, and treatment planning for conditions such as diabetic retinopathy and diabetic macular edema. The field brings together retinal imaging, optical coherence tomography, fundus photography, fluorescein angiography, and related clinical technologies. Demand is shaped by diabetes prevalence, aging populations, ophthalmology capacity, screening guidelines, reimbursement, and the need to detect disease before irreversible vision loss occurs.

Screening Integration and Workflow Redefine Device Adoption

The landscape is shifting from episodic specialist assessment toward integrated, risk-based eye-care pathways. Primary-care screening, teleophthalmology, portable imaging, automated referral, and longitudinal patient records are increasingly important because they can connect underserved patients with specialist services. Interoperability, ease of use, image quality, and rapid referral workflows are becoming as important as standalone device performance.

Artificial Intelligence Strengthens Triage, Detection, and Monitoring

Artificial intelligence is influencing diabetic eye disease care by supporting image quality assessment, lesion detection, severity classification, and referral prioritization. Its cumulative impact depends on representative training data, external validation, explainability, cybersecurity, regulatory clearance, and clinician oversight. AI is most valuable when embedded in a governed workflow that reduces avoidable delays without replacing specialist judgment.

Regional Insights: Uneven Access Drives Distinct Priorities

North America emphasizes advanced imaging, reimbursement alignment, workflow efficiency, and integration with established clinical networks. Europe is shaped by coordinated health systems, data-governance requirements, and screening consistency across countries. Asia-Pacific combines strong technology adoption in leading markets with substantial rural-access challenges. Latin America prioritizes affordable screening, mobile services, and referral connectivity, while the Middle East increasingly focuses on specialized care capacity and digitally enabled screening. Africa faces pronounced gaps in ophthalmic personnel, equipment availability, maintenance, and referral infrastructure, making portable and telemedicine-enabled solutions particularly relevant.

Group Insights: Health-System Coordination Shapes Deployment

ASEAN markets share a need for scalable screening models that can operate across diverse income levels, languages, and health-system structures. BRICS economies combine large diabetic populations with substantial variation in public and private care access, creating demand for adaptable technologies and local implementation capacity. The European Union places strong emphasis on cross-border data governance, clinical evidence, and harmonized care pathways. G7 systems generally have advanced specialist infrastructure but must address aging populations, workforce pressure, and cost-effective monitoring. GCC countries have strong potential for centralized screening programs and digitally connected specialty care. NATO members span varied health systems, making interoperability, procurement resilience, and equitable access important common considerations.

Country Insights: National Capacity and Policy Determine Use Cases

Australia and Canada face geographic dispersion and therefore benefit from teleophthalmology, mobile imaging, and coordinated referral. Brazil, Mexico, India, China, and Russia must balance major urban capabilities with rural and regional access gaps. France, Germany, Italy, Spain, and the United Kingdom have established ophthalmic services but continue to address capacity, waiting times, and pathway integration. Japan and South Korea combine advanced clinical technology with aging-population needs and strong expectations for quality and precision. The United States has broad access to sophisticated diagnostic services alongside persistent disparities linked to geography, income, and insurance coverage.

Priorities for Leaders: Build Connected, Evidence-Based Screening Pathways

Industry leaders should design devices around complete workflows rather than isolated examinations. Priorities include interoperability with clinical records, simple operator interfaces, robust image-quality controls, remote support, and service models suited to low-resource settings. AI deployments should use transparent validation, monitoring for bias and performance drift, and clear escalation to clinicians. Partnerships with health systems, primary-care providers, public-health programs, and training institutions can improve referral completion and long-term adoption. Evidence strategies should demonstrate clinical utility, operational efficiency, patient safety, and equitable performance across relevant populations.

Research Methodology: Structured Synthesis of Device and Care-Pathway Evidence

This executive summary uses a structured, qualitative assessment of the diabetic eye disease devices landscape. The analysis considers device functions, care settings, screening and diagnostic workflows, technology-enablement factors, regulatory and reimbursement conditions, infrastructure, workforce capacity, and regional access patterns. Insights are organized across the specified regions, country groupings, and countries. No market estimates, market sizing, market shares, forecasts, or company-specific claims are included.

Conclusion: Earlier Detection Requires Technology Plus System Design

Diabetic eye disease device adoption will depend on how effectively technologies connect detection with timely clinical action. Imaging quality, AI-supported triage, portability, interoperability, affordability, and service support must be evaluated together. Leaders that align product design with local workforce realities and measurable care pathways will be better positioned to improve screening reach, referral reliability, and preservation of vision across diverse health systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Diabetic Eye Disease Devices Market, by Technology
7.1. Introduction
7.2. Fluorescein Angiography
7.3. Fundus Camera
7.3.1. Mydriatic Fundus Camera
7.3.2. Nonmydriatic Fundus Camera
7.3.3. Ultra-widefield Fundus Camera
7.4. Indocyanine Green Angiography
7.5. Optical Coherence Tomography
7.5.1. Spectral Domain Optical Coherence Tomography
7.5.2. Swept Source Optical Coherence Tomography
7.5.3. Time Domain Optical Coherence Tomography
7.6. Ultrasound Imaging
7.6.1. A-Scan
7.6.2. B-Scan
8. Diabetic Eye Disease Devices Market, by Device Type
8.1. Introduction
8.2. Diagnostic Devices
8.2.1. Imaging Systems
8.2.2. Software
8.2.2.1. AI-Based Software
8.2.2.2. Conventional Software
8.3. Surgical Instruments
8.3.1. Endolaser Probes
8.3.2. Microincision Instruments
8.4. Therapeutic Devices
8.4.1. Implantable Devices
8.4.2. Injection Devices
8.4.2.1. Anti-VEGF Injection Devices
8.4.2.2. Steroid Injection Devices
8.4.3. Laser Systems
8.4.3.1. Argon Laser
8.4.3.2. Diode Laser
9. Diabetic Eye Disease Devices Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.2.1. Multi-specialty Centers
9.2.2. Single-specialty Centers
9.3. Clinics
9.3.1. Multi-specialty Clinics
9.3.2. Ophthalmology Clinics
9.4. Hospitals
9.4.1. Government Hospitals
9.4.2. Private Hospitals
9.5. Research Institutes
9.5.1. Private Research Institutes
9.5.2. Public Research Institutes
10. Diabetic Eye Disease Devices Market, by Application
10.1. Introduction
10.2. Diabetic Macular Edema
10.2.1. Diffuse Macular Edema
10.2.2. Focal Macular Edema
10.3. Diabetic Retinopathy
10.3.1. Nonproliferative Diabetic Retinopathy
10.3.2. Proliferative Diabetic Retinopathy
11. Diabetic Eye Disease Devices Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.2.1. Company Website Sales
11.2.2. OEM Direct Sales
11.3. Indirect Sales
11.3.1. Distributors
11.3.2. Online Channels
11.3.3. Retail Pharmacies
12. Diabetic Eye Disease Devices Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Diabetic Eye Disease Devices Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Diabetic Eye Disease Devices Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AbbVie Inc.
16.2. Alcon Inc.
16.3. Bausch + Lomb Corporation
16.4. Canon Medical Systems Corporation
16.5. Carl Zeiss Meditec AG
16.6. EssilorLuxottica SA
16.7. F. Hoffmann-La Roche Ltd
16.8. Heidelberg Engineering GmbH
16.9. IRIDEX Corporation
16.10. Johnson & Johnson Vision Care, Inc.
16.11. Lumenis Ltd.
16.12. NIDEK Co., Ltd.
16.13. NIDEK Co., Ltd.
16.14. Novartis AG
16.15. Optos plc
16.16. Optovue, Inc.
16.17. Regeneron Pharmaceuticals, Inc.
16.18. Santen Pharmaceutical Co., Ltd.
16.19. Topcon Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Diabetic Eye Disease Devices Market, Years Considered for the Study
FIGURE 2. Global Diabetic Eye Disease Devices Market, Research Design
FIGURE 3. Global Diabetic Eye Disease Devices Market, Research Framework
FIGURE 4. Global Diabetic Eye Disease Devices Market, Data Triangulation
FIGURE 5. Global Diabetic Eye Disease Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Diabetic Eye Disease Devices Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Diabetic Eye Disease Devices Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Diabetic Eye Disease Devices Market Size, by Device Type, 2025 vs 2032 (%)
FIGURE 9. Global Diabetic Eye Disease Devices Market Size, by Device Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Diabetic Eye Disease Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Diabetic Eye Disease Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Diabetic Eye Disease Devices Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Diabetic Eye Disease Devices Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Diabetic Eye Disease Devices Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Diabetic Eye Disease Devices Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Diabetic Eye Disease Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Diabetic Eye Disease Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Diabetic Eye Disease Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Diabetic Eye Disease Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Diabetic Eye Disease Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Diabetic Eye Disease Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Diabetic Eye Disease Devices Market Segmentation & Coverage
TABLE 2. Global Diabetic Eye Disease Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Diabetic Eye Disease Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Fluorescein Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Fluorescein Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Fluorescein Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Fundus Camera Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Fundus Camera Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Fundus Camera Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Mydriatic Fundus Camera Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Mydriatic Fundus Camera Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Mydriatic Fundus Camera Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Nonmydriatic Fundus Camera Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Nonmydriatic Fundus Camera Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Nonmydriatic Fundus Camera Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Ultra-widefield Fundus Camera Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Ultra-widefield Fundus Camera Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Ultra-widefield Fundus Camera Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Indocyanine Green Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Indocyanine Green Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Indocyanine Green Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Optical Coherence Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Optical Coherence Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Optical Coherence Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Spectral Domain Optical Coherence Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Spectral Domain Optical Coherence Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Spectral Domain Optical Coherence Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Swept Source Optical Coherence Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Swept Source Optical Coherence Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Swept Source Optical Coherence Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Time Domain Optical Coherence Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Time Domain Optical Coherence Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Time Domain Optical Coherence Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Ultrasound Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Ultrasound Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Ultrasound Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global A-Scan Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global A-Scan Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global A-Scan Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global B-Scan Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global B-Scan Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global B-Scan Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Diabetic Eye Disease Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 44. Global Diagnostic Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Diagnostic Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Diagnostic Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Imaging Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global AI-Based Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global AI-Based Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global AI-Based Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Conventional Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Conventional Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Conventional Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Surgical Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Surgical Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Surgical Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Endolaser Probes Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Endolaser Probes Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Endolaser Probes Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Microincision Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Microincision Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Microincision Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Therapeutic Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Therapeutic Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Therapeutic Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Implantable Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Implantable Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Implantable Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Injection Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Injection Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Injection Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Anti-VEGF Injection Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Anti-VEGF Injection Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Anti-VEGF Injection Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Steroid Injection Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Steroid Injection Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Steroid Injection Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Laser Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Laser Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Laser Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Argon Laser Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Argon Laser Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Argon Laser Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Diode Laser Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Diode Laser Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Diode Laser Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Diabetic Eye Disease Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Multi-specialty Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Multi-specialty Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Multi-specialty Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Single-specialty Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Single-specialty Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Single-specialty Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Multi-specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Multi-specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Multi-specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Ophthalmology Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Ophthalmology Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Ophthalmology Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Government Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Government Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Government Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Private Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Private Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Private Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Public Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Public Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Public Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Diabetic Eye Disease Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. Global Diabetic Macular Edema Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Diabetic Macular Edema Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Diabetic Macular Edema Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Diffuse Macular Edema Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Diffuse Macular Edema Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Diffuse Macular Edema Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Focal Macular Edema Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Focal Macular Edema Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Focal Macular Edema Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Diabetic Retinopathy Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Diabetic Retinopathy Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Diabetic Retinopathy Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Nonproliferative Diabetic Retinopathy Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Nonproliferative Diabetic Retinopathy Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Nonproliferative Diabetic Retinopathy Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Proliferative Diabetic Retinopathy Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Proliferative Diabetic Retinopathy Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Proliferative Diabetic Retinopathy Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Diabetic Eye Disease Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Company Website Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Company Website Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Company Website Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global OEM Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global OEM Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global OEM Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Indirect Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Indirect Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Indirect Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Online Channels Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Global Online Channels Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. Global Online Channels Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Diabetic Eye Disease Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Fundus Camera, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Optical Coherence Tomography, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Ultrasound Imaging, 2017-2032 (USD Million)
TABLE 176. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 177. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Diagnostic Devices, 2017-2032 (USD Million)
TABLE 178. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Software, 2017-2032 (USD Million)
TABLE 179. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 180. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 181. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Injection Devices, 2017-2032 (USD Million)
TABLE 182. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Laser Systems, 2017-2032 (USD Million)
TABLE 183. Asia-Pacific Diabetic Eye Disease Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 185. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 186. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 187. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 188. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Diabetic Macular Edema, 2017-2032 (USD Million)
TABLE 190. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Diabetic Retinopathy, 2017-2032 (USD Million)
TABLE 191. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 192. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 193. Asia-Pacific Diabetic Eye Disease Devices Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 194. North America Diabetic Eye Disease Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 195. North America Diabetic Eye Disease Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. North America Diabetic Eye Disease Devices Market Size, by Fundus Camera, 2017-2032 (USD Million)
TABLE 197. North America Diabetic Eye Disease Devices Market Size, by Optical Coherence Tomography, 2017-2032 (USD Million)
TABLE 198. North America Diabetic Eye Disease Devices Market Size, by Ultrasound Imaging, 2017-2032 (USD Million)
TABLE 199. North America Diabetic Eye Disease Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 200. North America Diabetic Eye Disease Devices Market Size, by Diagnostic Devices, 2017-2032 (USD Million)
TABLE 201. North America Diabetic Eye Disease Devices Market Size, by Software, 2017-2032 (USD Million)
TABLE 202. North America Diabetic Eye Disease Devices Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 203. North America Diabetic Eye Disease Devices Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 204. North America Diabetic Eye Disease Devices Market Size, by Injection Devices, 2017-2032 (USD Million)
TABLE 205. North America Diabetic Eye Disease Devices Market Size, by Laser Systems, 2017-2032 (USD Million)
TABLE 206. North America Diabetic Eye Disease Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. North America Diabetic Eye Disease Devices Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 208. North America Diabetic Eye Disease Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 209. North America Diabetic Eye Disease Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 210. North America Diabetic Eye Disease Devices Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 211. North America Diabetic Eye Disease Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. North America Diabetic Eye Disease Devices Market Size, by Diabetic Macular Edema, 2017-2032 (USD Million)
TABLE 213. North America Diabetic Eye Disease Devices Market Size, by Diabetic Retinopathy, 2017-2032 (USD Million)
TABLE 214. North America Diabetic Eye Disease Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 215. North America Diabetic Eye Disease Devices Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 216. North America Diabetic Eye Disease Devices Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 217. Latin America Diabetic Eye Disease Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 218. Latin America Diabetic Eye Disease Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 219. Latin America Diabetic Eye Disease Devices Market Size, by Fundus Camera, 2017-2032 (USD Million)
TABLE 220. Latin America Diabetic Eye Disease Devices Market Size, by Optical Coherence Tomography, 2017-2032 (USD Million)
TABLE 221. Latin America Diabetic Eye Disease Devices Market Size, by Ultrasound Imaging, 2017-2032 (USD Million)
TABLE 222. Latin America Diabetic Eye Disease Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 223. Latin America Diabetic Eye Disease Devices Market Size, by Diagnostic Devices, 2017-2032 (USD Million)
TABLE 224. Latin America Diabetic Eye Disease Devices Market Size, by Software, 2017-2032 (USD Million)
TABLE 225. Latin America Diabetic Eye Disease Devices Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 226. Latin America Diabetic Eye Disease Devices Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 227. Latin America Diabetic Eye Disease Devices Market Size, by Injection Devices, 2017-2032 (USD Million)
TABLE 228. Latin America Diabetic Eye Disease Devices Market Size, by Laser Systems, 2017-2032 (USD Million)
TABLE 229. Latin America Diabetic Eye Disease Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Latin America Diabetic Eye Disease Devices Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 231. Latin America Diabetic Eye Disease Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 232. Latin America Diabetic Eye Disease Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 233. Latin America Diabetic Eye Disease Devices Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 234. Latin America Diabetic Eye Disease Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. Latin America Diabetic Eye Disease Devices Market Size, by Diabetic Macular Edema, 2017-2032 (USD Million)
TABLE 236. Latin America Diabetic Eye Disease Devices Market Size, by Diabetic Retinopathy, 2017-2032 (USD Million)
TABLE 237. Latin America Diabetic Eye Disease Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 238. Latin America Diabetic Eye Disease Devices Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 239. Latin America Diabetic Eye Disease Devices Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 240. Europe Diabetic Eye Disease Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 241. Europe Diabetic Eye Disease Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 242. Europe Diabetic Eye Disease Devices Market Size, by Fundus Camera, 2017-2032 (USD Million)
TABLE 243. Europe Diabetic Eye Disease Devices Market Size, by Optical Coherence Tomography, 2017-2032 (USD Million)
TABLE 244. Europe Diabetic Eye Disease Devices Market Size, by Ultrasound Imaging, 2017-2032 (USD Million)
TABLE 245. Europe Diabetic Eye Disease Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 246. Europe Diabetic Eye Disease Devices Market Size, by Diagnostic Devices, 2017-2032 (USD Million)
TABLE 247. Europe Diabetic Eye Disease Devices Market Size, by Software, 2017-2032 (USD Million)
TABLE 248. Europe Diabetic Eye Disease Devices Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 249. Europe Diabetic Eye Disease Devices Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 250. Europe Diabetic Eye Disease Devices Market Size, by Injection Devices, 2017-2032 (USD Million)
TABLE 251. Europe Diabetic Eye Disease Devices Market Size, by Laser Systems, 2017-2032 (USD Million)
TABLE 252. Europe Diabetic Eye Disease Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. Europe Diabetic Eye Disease Devices Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 254. Europe Diabetic Eye Disease Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 255. Europe Diabetic Eye Disease Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 256. Europe Diabetic Eye Disease Devices Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 257. Europe Diabetic Eye Disease Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. Europe Diabetic Eye Disease Devices Market Size, by Diabetic Macular Edema, 2017-2032 (USD Million)
TABLE 259. Europe Diabetic Eye Disease Devices Market Size, by Diabetic Retinopathy, 2017-2032 (USD Million)
TABLE 260. Europe Diabetic Eye Disease Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. Europe Diabetic Eye Disease Devices Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 262. Europe Diabetic Eye Disease Devices Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 263. Middle East Diabetic Eye Disease Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 264. Middle East Diabetic Eye Disease Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 265. Middle East Diabetic Eye Disease Devices Market Size, by Fundus Camera, 2017-2032 (USD Million)
TABLE 266. Middle East Diabetic Eye Disease Devices Market Size, by Optical Coherence Tomography, 2017-2032 (USD Million)
TABLE 267. Middle East Diabetic Eye Disease Devices Market Size, by Ultrasound Imaging, 2017-2032 (USD Million)
TABLE 268. Middle East Diabetic Eye Disease Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 269. Middle East Diabetic Eye Disease Devices Market Size, by Diagnostic Devices, 2017-2032 (USD Million)
TABLE 270. Middle East Diabetic Eye Disease Devices Market Size, by Software, 2017-2032 (USD Million)
TABLE 271. Middle East Diabetic Eye Disease Devices Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 272. Middle East Diabetic Eye Disease Devices Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 273. Middle East Diabetic Eye Disease Devices Market Size, by Injection Devices, 2017-2032 (USD Million)
TABLE 274. Middle East Diabetic Eye Disease Devices Market Size, by Laser Systems, 2017-2032 (USD Million)
TABLE 275. Middle East Diabetic Eye Disease Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. Middle East Diabetic Eye Disease Devices Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 277. Middle East Diabetic Eye Disease Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 278. Middle East Diabetic Eye Disease Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 279. Middle East Diabetic Eye Disease Devices Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 280. Middle East Diabetic Eye Disease Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. Middle East Diabetic Eye Disease Devices Market Size, by Diabetic Macular Edema, 2017-2032 (USD Million)
TABLE 282. Middle East Diabetic Eye Disease Devices Market Size, by Diabetic Retinopathy, 2017-2032 (USD Million)
TABLE 283. Middle East Diabetic Eye Disease Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. Middle East Diabetic Eye Disease Devices Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 285. Middle East Diabetic Eye Disease Devices Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 286. Africa Diabetic Eye Disease Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 287. Africa Diabetic Eye Disease Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 288. Africa Diabetic Eye Disease Devices Market Size, by Fundus Camera, 2017-2032 (USD Million)
TABLE 289. Africa Diabetic Eye Disease Devices Market Size, by Optical Coherence Tomography, 2017-2032 (USD Million)
TABLE 290. Africa Diabetic Eye Disease Devices Market Size, by Ultrasound Imaging, 2017-2032 (USD Million)
TABLE 291. Africa Diabetic Eye Disease Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 292. Africa Diabetic Eye Disease Devices Market Size, by Diagnostic Devices, 2017-2032 (USD Million)
TABLE 293. Africa Diabetic Eye Disease Devices Market Size, by Software, 2017-2032 (USD Million)
TABLE 294. Africa Diabetic Eye Disease Devices Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 295. Africa Diabetic Eye Disease Devices Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 296. Africa Diabetic Eye Disease Devices Market Size, by Injection Devices, 2017-2032 (USD Million)
TABLE 297. Africa Diabetic Eye Disease Devices Market Size, by Laser Systems, 2017-2032 (USD Million)
TABLE 298. Africa Diabetic Eye Disease Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Africa Diabetic Eye Disease Devices Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 300. Africa Diabetic Eye Disease Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 301. Africa Diabetic Eye Disease Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 302. Africa Diabetic Eye Disease Devices Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 303. Africa Diabetic Eye Disease Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. Africa Diabetic Eye Disease Devices Market Size, by Diabetic Macular Edema, 2017-2032 (USD Million)
TABLE 305. Africa Diabetic Eye Disease Devices Market Size, by Diabetic Retinopathy, 2017-2032 (USD Million)
TABLE 306. Africa Diabetic Eye Disease Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 307. Africa Diabetic Eye Disease Devices Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 308. Africa Diabetic Eye Disease Devices Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 309. Global Diabetic Eye Disease Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 310. ASEAN Diabetic Eye Disease Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 311. ASEAN Diabetic Eye Disease Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 312. ASEAN Diabetic Eye Disease Devices Market Size, by Fundus Camera, 2017-2032 (USD Million)
TABLE 313. ASEAN Diabetic Eye Disease Devices Market Size, by Optical Coherence Tomography, 2017-2032 (USD Million)
TABLE 314. ASEAN Diabetic Eye Disease Devices Market Size, by Ultrasound Imaging, 2017-2032 (USD Million)
TABLE 315. ASEAN Diabetic Eye Disease Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 316. ASEAN Diabetic Eye Disease Devices Market Size, by Diagnostic Devices, 2017-2032 (USD Million)
TABLE 317. ASEAN Diabetic Eye Disease Devices Market Size, by Software, 2017-2032 (USD Million)
TABLE 318. ASEAN Diabetic Eye Disease Devices Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 319. ASEAN Diabetic Eye Disease Devices Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 320. ASEAN Diabetic Eye Disease Devices Market Size, by Injection Devices, 2017-2032 (USD Million)
TABLE 321. ASEAN Diabetic Eye Disease Devices Market Size, by Laser Systems, 2017-2032 (USD Million)
TABLE 322. ASEAN Diabetic Eye Disease Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. ASEAN Diabetic Eye Disease Devices Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 324. ASEAN Diabetic Eye Disease Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 325. ASEAN Diabetic Eye Disease Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 326. ASEAN Diabetic Eye Disease Devices Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 327. ASEAN Diabetic Eye Disease Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 328. ASEAN Diabetic Eye Disease Devices Market Size, by Diabetic Macular Edema, 2017-2032 (USD Million)
TABLE 329. ASEAN Diabetic Eye Disease Devices Market Size, by Diabetic Retinopathy, 2017-2032 (USD Million)
TABLE 330. ASEAN Diabetic Eye Disease Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 331. ASEAN Diabetic Eye Disease Devices Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 332. ASEAN Diabetic Eye Disease Devices Market Size, by Indirect Sales, 2017-2032 (USD Million)
TABLE 333. GCC Diabetic Eye Disease Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 334. GCC Diabetic Eye Disease Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 335. GCC Diabetic Eye Disease Devices Market Size, by Fundus Camera, 2017-2032 (USD Million)
TABLE 336. GCC Diabetic Eye Disease Devices Market Size, by Optical Coherence Tomography, 2017-2032 (USD Million)
TABLE 337. GCC Diabetic Eye Disease Devices Market Size, by Ultrasound Imaging, 2017-2032 (USD Milli

Companies Mentioned

  • AbbVie Inc.
  • Alcon Inc.
  • Bausch + Lomb Corporation
  • Canon Medical Systems Corporation
  • Carl Zeiss Meditec AG
  • EssilorLuxottica SA
  • F. Hoffmann-La Roche Ltd
  • Heidelberg Engineering GmbH
  • IRIDEX Corporation
  • Johnson & Johnson Vision Care, Inc.
  • Lumenis Ltd.
  • NIDEK Co., Ltd.
  • NIDEK Co., Ltd.
  • Novartis AG
  • Optos plc
  • Optovue, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Topcon Corporation

Related Topics

Related Reports

Diabetic Eye Disease Devices - Global Strategic Business Report - Product Image

Diabetic Eye Disease Devices - Global Strategic Business Report

  • Report
  • 270 Pages
  • Global
From
Immunosuppressive Therapy for Eye Diseases Market - Global Forecast 2026-2032 - Product Image

Immunosuppressive Therapy for Eye Diseases Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Thyroid Eye Disease Treatments Market - Global Forecast 2026-2032 - Product Image

Thyroid Eye Disease Treatments Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Dry Eye Disease - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Dry Eye Disease - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Dry Eye Disease Market Outlook 2026-2034: Market Share, and Growth Analysis by Type, Disease Type, Dosage Form, Distribution Channel - Product Image

Dry Eye Disease Market Outlook 2026-2034: Market Share, and Growth Analysis by Type, Disease Type, Dosage Form, Distribution Channel

  • Report
  • 160 Pages
  • Global
From

About the Market

Within the realm of optics, the diabetic eye disease devices market encompasses a range of medical devices and equipment designed for the screening, diagnosis, management, and treatment of eye conditions associated with diabetes. One of the most common complications of diabetes is diabetic retinopathy, which can lead to deterioration in vision and, ultimately, blindness if left untreated. Consequently, the market for diabetic eye disease devices includes but is not limited to fundus cameras, OCT (optical coherence tomography) devices, fluorescein angiography equipment, laser treatment devices, and retinal screening systems. These devices aid eye care professionals in monitoring the progression of retinal diseases, facilitating early detection, and providing therapeutic interventions that can preserve vision. Innovations in this sector often focus on enhancing imaging capabilities, improving patient comfort, and integrating with health informatics systems to streamline the workflow in ophthalmic clinics. Several notable companies operating within the diabetic eye disease devices market include Topcon Corporation, which provides imaging and laser systems for eye care; Carl Zeiss AG, known for their optical and optoelectronic technology; and Optos plc, which offers ultra-widefield retinal imaging devices. Other key players in this sector are Canon Inc., focusing on digital imaging, and NIDEK Co., Ltd., which manufactures comprehensive eye examination and treatment devices. These companies are among the leaders in advancing the technology that supports eye care professionals in managing diabetes-related eye diseases. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.